Ben Stutzman

Ben Stutzman is an experienced healthcare professional with a focus on oncology and field access in the pharmaceutical sector. Currently serving as the Director of Field Access at Deciphera Pharmaceuticals since March 2020, Stutzman has held various roles within the company, including Associate Director and Oncology Territory Manager for Rare Disease. Prior to Deciphera, Stutzman worked at Genentech from July 2015 to March 2020 as a Senior Clinical Oncology Specialist specializing in cancer immunotherapy, specifically with the drug Tecentriq. Stutzman’s career began at AstraZeneca as a Cardiovascular Sales Specialist from July 2008 to July 2015 and included a foundational role in education as a teacher and coach at Lewisville ISD from August 2003 to July 2008. Stutzman holds a Bachelor of Science degree in Kinesiology and Biology from Texas Lutheran University, earned between 1999 and 2003, and is a graduate of Rockport-Fulton High School.